TEM: Tempus AI, Inc.
About
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.
Current Value
$53.201 Year Return
Current Value
$53.201 Year Return
Key Details
Market Cap
$8.26B
P/E Ratio
1Y Stock Return
0.00%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
151.7
Strategies that include TEM
Stock's related to TEM
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ADBE | 53.96% | $222.05B | -18.60% | 0.00% |
| OCUL | 44.51% | $1.34B | +282.06% | 0.00% |
| HVT | 41.96% | $379.52M | -25.02% | 5.34% |
| CIM | 40.27% | $1.18B | -3.69% | 6.41% |
| AFYA | 39.88% | $1.47B | -18.74% | 0.00% |
| IRON | 37.76% | $1.89B | +22.13% | 0.00% |
| EVCM | 36.64% | $2.14B | +31.79% | 0.00% |
| ELME | 35.44% | $1.40B | +21.61% | 4.54% |
| HAS | 35.32% | $8.64B | +35.71% | 4.52% |
| PD | 34.18% | $1.85B | -6.90% | 0.00% |
| DXYZ | 31.65% | - | - | 0.00% |
| TMCI | 31.17% | $494.64M | -8.00% | 0.00% |
| WK | 31.04% | $5.26B | +0.72% | 0.00% |
| BILL | 31.04% | $9.31B | +41.43% | 0.00% |
| CRVL | 30.90% | $6.17B | +70.04% | 0.00% |
| TLPH | 30.58% | $11.91M | +9.27% | 0.00% |
| OSUR | 29.93% | $287.19M | -46.90% | 0.00% |
| HPP | 29.89% | $430.76M | -42.23% | 3.24% |
| FRHC | 29.68% | $7.11B | +40.56% | 0.00% |
| KD | 29.67% | $7.55B | +79.01% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SSYS | -<0.01% | $661.43M | -14.64% | 0.00% |
| YMAB | <0.01% | $452.37M | +85.32% | 0.00% |
| CPRX | -0.01% | $2.52B | +52.38% | 0.00% |
| BTU | -0.01% | $3.42B | +19.29% | 1.07% |
| SAIA | 0.01% | $14.61B | +29.76% | 0.00% |
| INCY | 0.02% | $13.56B | +31.82% | 0.00% |
| LSTR | 0.02% | $6.34B | +3.87% | 0.76% |
| AOUT | 0.02% | $122.95M | +13.64% | 0.00% |
| KSPI | 0.02% | $19.73B | +8.16% | 3.55% |
| IRS | 0.03% | $1.26B | +117.80% | 4.01% |
| ARLO | 0.03% | $1.19B | +30.66% | 0.00% |
| CAT | -0.03% | $188.10B | +58.36% | 1.39% |
| HWKN | 0.03% | $2.68B | +105.84% | 0.52% |
| KOF | 0.04% | $4.09B | -8.76% | 4.29% |
| KRO | -0.05% | $1.34B | +40.90% | 5.32% |
| PLUG | -0.05% | $1.72B | -45.69% | 0.00% |
| VBTX | 0.06% | $1.60B | +52.65% | 2.71% |
| ZIMV | 0.06% | $379.21M | +50.33% | 0.00% |
| F | -0.06% | $42.92B | +6.79% | 5.51% |
| RUM | 0.06% | $1.82B | +26.38% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NNVC | -23.61% | $18.36M | +17.97% | 0.00% |
| TTE | -22.84% | $136.90B | -11.84% | 5.62% |
| ENV | -21.76% | $3.49B | +70.05% | 0.00% |
| QXO | -21.27% | $6.81B | -33.42% | 0.00% |
| BACK | -17.94% | $1.93M | -32.12% | 0.00% |
| SNY | -17.79% | $120.29B | +3.27% | 4.24% |
| APD | -17.32% | $73.11B | +19.91% | 2.14% |
| ACGL | -16.71% | $37.09B | +20.63% | 0.00% |
| KSS | -16.59% | $1.82B | -29.22% | 11.92% |
| WES | -16.07% | $14.43B | +33.37% | 8.38% |
| LBRT | -16.02% | $3.00B | -6.23% | 1.50% |
| ACIU | -15.67% | $327.95M | +8.58% | 0.00% |
| MSM | -15.09% | $4.70B | -14.77% | 3.96% |
| CORT | -15.06% | $5.86B | +120.68% | 0.00% |
| TTEK | -14.44% | $10.92B | +23.94% | 2.70% |
| AGIO | -14.32% | $3.17B | +152.91% | 0.00% |
| VSTA | -14.28% | $203.32M | -37.79% | 0.00% |
| E | -14.26% | $45.95B | -10.47% | 7.33% |
| K | -14.26% | $27.93B | +52.93% | 2.77% |
| TRS | -14.19% | $1.08B | +9.60% | 0.61% |
ETF's related to TEM
News
Finnhub
CHICAGO - Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the collaboration with Flatiron Health, a leading healthtech...
SeekingAlpha
Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its partnerships with Merck and BioNTech.
Yahoo
CHICAGO, November 12, 2024--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the collaboration with Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point of care solutions in oncology, to integrate its comprehensive genomic testing directly into Flatiron’s cloud-based Electronic Medical Record (EMR) platform, OncoEMR® through the Molecular Profiling Integration
Yahoo
CHICAGO, November 11, 2024--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, "Actionable structural variant detection via RNA-NGS and DNA-NGS in patients with advanced non-small cell lung cancer," in JAMA Network Open.
Finnhub
CHICAGO - Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced nine abstracts were accepted for presentation at the Society...
SeekingAlpha
The market surged after Trump's victory, likely starting a new trending period with strong technicals and favorable end-of-year conditions. Read more here.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.